Weekly 52-week high companies: Cigna Corp (CI), Seadrill Ltd (SDRL), Harley-Davidson Inc. (HOG), Life Technologies Corp. (LIFE), and Vodafone Group PLC (VOD).
Cigna Corp (CI) Reached the 52-Week High of $78.69
The prices of Cigna Corp (CI) shares have reached $78.69, which is 1.7% off the 52-week high of $79.99. Cigna Corp was incorporated in the State of Delaware in 1981. Cigna Corp has a market cap of $22.26 billion; its shares were traded at around $78.69 with a P/E ratio of 15.58 and P/S ratio of 0.73. The dividend yield of Cigna Corp stocks is 0.05%. Cigna Corp had an annual average earnings growth of 10.4% over the past 10 years.
On May 02, Cigna Corporation reported first quarter 2013 consolidated revenues of $8.2 billion, an increase of 21% over the first quarter of 2012. Cigna's adjusted income from operations1 for the first quarter of 2013 was $497 million, or $1.72 per share. This result compares with $359 million, or $1.24 per share, for the first quarter of 2012. Adjusted income from operations1 in the first quarter of 2013 reflects strong revenue growth, favorable operating expenses and medical costs, including favorable prior year reserve development in the Global Health Care business of $48 million after-tax, or $0.17 per share.
Top 5 Information Technology Companies To Watch For 2015: DCT Industrial Trust Inc (DCF)
DCT Industrial Trust Inc. (DCT) is an industrial real estate company that owns, operates and develops bulk distribution and light industrial properties in distribution markets in the United States and Mexico. The Company is structured as an umbrella partnership real estate investment trust (REIT), under which substantially all of its business is, and will be, conducted through a majority-owned and controlled subsidiary, DCT Industrial Operating Partnership LP (the operating partnership), a Delaware limited partnership, for which DCT Industrial Trust Inc. is the sole general partner. The Company owns properties through its operating partnership and its subsidiaries. As of December 31, 2011, DCT owned approximately 90% of the outstanding equity interests in its operating partnership. In March 2012, DCT acquired a 32.6 acre land parcel in Romeoville, within the southern I-55 industrial submarket of Chicago. In May 2012, the Company acquired two Class A industrial buildings totaling 98,000 square feet in Houston, known as DCT Claymoore Center. Located in the Northwest submarket of Houston, DCT Claymoore Center encompasses a bulk and light industrial facility and is 95.8%-occupied. In August 2013, the Company announced that it has acquired a three building portfolio totaling 308,000 square feet in the Tempe/Airport submarket of Phoenix. In September 2013, Dct Industrial Trust Inc announced the acquisition of 45 acres in the heart of the Inland Empire West submarket of Southern California. In October 2013, DCT Industrial Trust Inc acquired DCT Fox River Business Center, a six-building industrial portfolio in Elgin. In October 2013, DCT Industrial Trust Inc sold its entire portfolio of Mexico assets to an investment trust of Macquarie Mexican REIT.
During the year ended December 31, 2011, the Company acquired 24 buildings comprising 2.8 million square feet and controlling ownership interests in three buildings totaling 0.4 million square feet. In 2011, the Company sold 16 operating properties to! taling approximately 2.7 million square feet to third-parties. As of December 31, 2011, the Company�� consolidated operating properties had leases with approximately 900 customers with no single customer accounting for more than 1.7% of the total annualized base rents of its properties. As of December 31, 2011, the Company owned interests in, managed or had under development approximately 75.5 million square feet of properties leased to approximately 900 customers, including 58.1 million square feet comprising 408 consolidated properties owned in its operating portfolio, which were 90.6% occupied; 0.2 million square feet comprising one consolidated property under redevelopment, and 17.2 million square feet comprising 52 unconsolidated properties, which were 86.3% occupied and one managed-only property operated on behalf of five institutional capital management partners. As of December 31, 2011, its total consolidated portfolio consisted of 409 properties with an average size of 142,000 square feet and an average age of 20.2 years.
Advisors' Opinion:- [By GuruFocus]
Free cash flow is a favorite parameter of value investors. It seems to make sense, because the value of a company is determined by how much cash it can generate over time. Value investors have developed discounted cash flow (DCF) models to estimate the value of companies.
10 Best Integrated Utility Stocks To Watch For 2014: Elan Corporation PLC (ELN)
Elan Corporation, plc (Elan), incorporated in December 1969, is a neuroscience-based biotechnology company. The Company is focused on discovering and developing advanced therapies in neurodegenerative and autoimmune diseases. Elan�� business focuses on neurodegenerative diseases, such as Alzheimer�� disease and Parkinson�� disease; autoimmune diseases, including MS and Crohn�� disease and neo-epitope based targets for treatments across a range of therapeutic indications. Tysabri is a treatment for MS and Crohn�� disease that the Company markets and distributes with Biogen Idec. On September 16, 2011, Elan sold its EDT business to Alkermes, Inc. In November 2011, Elan launched a collaboration with the University of Cambridge, England, the Cambridge-Elan Centre for Research Innovation and Drug Discovery (Cambridge-Elan Centre). On December 21, 2012, the Company completed the demerger of Prothena Corporation plc. In April 2013, it closed the TYSABRI (natalizumab) Collaboration Transaction with Biogen Idec.
Tysabri
Tysabri, which is an alpha-4 integrin inhibitor, is a therapy for MS, a neurological disorder involving central nervous system dysfunction among adults. Tysabri is approved in more than 65 countries. Tysabri is approved in the United States as a monotherapy for relapsing forms of MS, for patients who have had an inadequate response to, or are unable to tolerate, an alternative MS therapy. In the European Union, it is approved for relapsing-remitting MS (RRMS) in adult patients who have failed to respond to beta interferon or have rapidly evolving, severe RRMS. As of December 31, 2011, there were approximately 64,400 patients on Tysabri therapy worldwide.
In June 2011, the European Commission (EC) approved the inclusion of the anti-JCV antibody status as an additional factor in stratifying patients at risk for developing PML in the Summary of Product Characteristics��(SmPC) for Tysabri in the European Union. The Company has developed a two-step ! enzyme-linked immunosorbent assay (ELISA), STRATIFY JCV, with Biogen Idec. The assay detects anti-JCV antibodies in the blood of patients, and is commercially available in Europe. In January 2012, the FDA cleared the assay for commercial use in the United States. As of December 31, 2011, over 80,000 tests had been administered using the assay. Tysabri is marketed and distributed by Elan and Biogen Idec. The Company�� research group, Neotope, is focused on creating monoclonal antibodies based on neo-epitope targets for the treatment of a range of therapeutic indications.
Beta Amyloid Immunotherapies (AIP)
Beta amyloid immunotherapy includes the treatment of Alzheimer�� disease by inducing or enhancing the body�� immune response in order to clear toxic species of beta amyloid from the brain. The AIP includes bapineuzumab (intravenous and subcutaneous delivery) and ACC-001, as well as other compounds. Bapineuzumab is an experimental humanized monoclonal antibody delivered intravenously that is being studied as a treatment for mild to moderate Alzheimer�� disease. It is designed to provide antibodies to beta amyloid directly to the patient (passive immunotherapy).
ELND005, an A� Aggregation Inhibitor
The small molecule ELND005 (Scyllo-inositol) is a beta amyloid anti-aggregation agent. Preclinical data suggest that ELND005 may act through the mechanism of preventing and reversing the fibrilisation of beta amyloid (the aggregation of beta amyloid into clumps of insoluble oligomers). ELND005 may have additional applications in psychiatric indications, such as bipolar disorder. In November 2011, the Company entered into a manufacturing agreement for the supply of the active pharmaceutical ingredient for ELND005 with Lonza Group AG.
Neotope Biosciences Limited
Neotope Biosciences Limited (Neotope) is the Company�� wholly owned subsidiary that focuses on the discovery and development of antibodies to neo-epitope related targ! ets for t! he treatment of a range of indications. It includes amyloidosis, diabetes, cancer and macular degeneration. Neotope�� portfolio of targets includes alpha-synuclein for the potential treatment of synucleinopathies, such as Lewy body dementia and Parkinson�� disease, tau for Alzheimer�� disease and other tauopathies. It also has a program for type 2-diabetes.
Onclave Therapeutics Limited
Elan�� wholly owned subsidiary Onclave Therapeutics Limited (Onclave) was formed to develop assets originating from Elan that have application in oncology related diseases. Onclave�� program, NEOD001, which originated from Neotope, is being investigated for the treatment of AL amyloidosis, which is a fatal disease involving abnormal accumulation of amyloid in organs and tissue. During the year ended December 31, 2011, Onclave filed for orphan drug designation of NEOD001. Onclave�� pipeline includes additional compounds with relevance in diverse cancer indications.
The Company competes with Biogen Idec, Bayer Schering Pharma AG, Bayer Schering Pharma, Merck Serono, Pfizer, Teva Neurosciences, Inc., Sanofi-Aventis and Novartis AG.
Advisors' Opinion:- [By Sofia Horta e Costa]
Bellway Plc (BWY) added 1.4 percent after the homebuilder said reservations in the past four months rose 31 percent as buyers had greater access to mortgages. Elan (ELN) Corp. jumped to a 10-month high in Dublin after Royalty Pharma increased its offer for the Irish drugmaker to as much as $6.7 billion. BT Group increased 3.7 percent as Barclays Plc recommended investors buy shares of the U.K.�� largest fixed-line company.
- [By Sean Williams]
Elan (NYSE: ELN )
Having a lot of cash in the biotech sector doesn't mean that a company's clinical trials will translate into success. Elan's claim to fame was the development of multiple sclerosis drug Tysabri, which it licensed out to Biogen Idec (NASDAQ: BIIB ) . Sales of the drug hit $1.6 billion last year. - [By Brian Orelli]
Most recently Elan (NYSE: ELN ) spun out its drug discovery business into Prothena. Without the burden of a drug discovery unit, the parent company is now being pursued by Royalty Pharma, although Elan isn't keen on its current offer.
10 Best Integrated Utility Stocks To Watch For 2014: Liquidmetal Technologies Inc (LQMT)
Liquidmetal Technologies, Inc. (Liquidmetal Technologies), incorporated in 1987, is materials technology company that develops and commercializes products made from amorphous alloys. The Company's Liquidmetal family of alloys consists of a variety of bulk alloys and composites that utilize the advantages offered by amorphous alloy technology. The Company designs develop and sell products and components from bulk amorphous alloys to customers in various industries. The Company also partners with third-party manufacturers and licensees to develop and commercialize Liquidmetal alloy products. The Company focused to commercializes its Liquidmetal alloys on three identified product areas, such as Components for Non-Consumer Electronic Products, Sporting Goods and Leisure Products and Medical Devices. On December 1, 2011, the Company entered into a Share Purchase Agreement with LMTK Holdings, Inc. (LMTK Holdings) to sell its former Korean subsidiary and manufacturing facility, Liquidmetal Technologies Korea (LMTK). Under the Share Purchase Agreement, the Company sold all of LMTK�� shares of common stock to LMTK Holdings.
The Company designs, develops and produces components for non-consumer electronic devices utilizing its bulk Liquidmetal alloys. The product categories in the non-consumer electronics field include, but are not limited to, parts for high end printers, commercial imaging devices, aerospace components, medical devices and industrial machines. The Company is also developing a variety of applications for Liquidmetal alloys in the sporting goods and leisure products area.
The Company develops a variety of applications for Liquidmetal alloys in the sporting goods and leisure products area. In the sporting goods industry the Company focuses on products that meet its design criteria. The Company has produced prototype rings made from an amorphous Liquidmetal platinum alloy that is harder, in the leisure products category. The Company emphasis on surgical instrument appl! ications for Liquidmetal alloys. These include, but are not limited to, specialized blades, orthopedic instruments utilized for implant surgery procedures, dental devices and general surgery devices
The Company is engaged in product development efforts relating to various medical devices that could be made from bulk Liquidmetal alloys. The properties of bulk Liquidmetal alloys provide a combination of performance that makes them a replacement to incumbent materials, such as stainless steel and titanium.
Advisors' Opinion:- [By James E. Brumley]
The 7% pop we're seeing from Liquidmetal Technologies Inc. (OTCBB:LQMT) today is impressive, but we've all seen big - and even bigger - gains from stocks before. What makes this one any different than the hundred of other stocks that dole out one-day wonder gains on any given trading day? Well, as it turns out, there actually is something significantly different with the way LQMT is flying high today.
- [By John Udovich]
On Wednesday, small cap Liquidmetal Technologies Inc (OTCBB: LQMT) spiked 223.2% on renewed speculation about Apple (NASDAQ: AAPL) having won a patent for a process to mass produce Liquidmetal, but what�� the whole story for investors?
- [By James E. Brumley]
Looking for a couple of near-term trades that have a decent shot at rallying even if the broad market feels like it might pull back? Then take a look at Liquidmetal Technologies Inc. (OTCBB:LQMT) and NanoTech Entertainment, Inc. (OTCMKTS:NTEK). Although both LQMT and NTEK will be dismissed by some traders simply because they're OTC-listed stocks, for those traders willing to look past the exchange and appreciate the opportunity, the risk-versus-reward ratio is actually quite compelling.
- [By Bryan Murphy]
With just a quick glance at its chart, Liquidmetal Technologies Inc. (OTCBB:LQMT) looks like little more than a tangled, indecisive mess. As you take a longer look at LQMT chart though, a modest bullish hint starts to appear. This may be one of the budding superstar stocks for Q4.
10 Best Integrated Utility Stocks To Watch For 2014: Big Lots Inc (BIG)
Big Lots, Inc., incorporated in May 2001, through its wholly owned subsidiaries, is a North America's closeout retailer. At January 28, 2012, the Company operated a total of 1,533 stores in two countries: the United States and Canada. The Company operates in two segments: U.S. and Canada. The merchandising categories include Consumables, Furniture, Home, Seasonal, Play n' Wear, and Hardlines & Other. The Consumables category includes the food, health and beauty, plastics, paper, chemical, and pet departments. The Furniture category includes the upholstery, mattresses, ready-to-assemble, and case goods departments. The Home category includes the domestics, stationery, and home decorative departments. The Seasonal category includes the lawn and garden, Christmas, summer, and other holiday departments. The Play n' Wear category includes the electronics, toys, jewelry, infant accessories, and apparel departments. The Hardlines & Other category includes the appliances, tools, paint, and home maintenance departments. On July 18, 2011, the Company acquired Liquidation World Inc. During the fiscal year ended January 28, 2012 (fiscal 2011), the Company opened 92 stores, acquired 89 stores and closed 46 stores.
All of the Company�� stores are located in North America and has an average store size of approximately 29,900 square feet, of which an average of 21,600 square feet is selling square feet. The 54 owned stores are located in Arizona, California, Colorado, Florida, Louisiana, New Mexico, Ohio and Texas. At January 28, 2012, the Company owned or leased approximately 9.4 million square feet of distribution center and warehouse space. The Company leases and operates two regional distribution centers in Canada located in British Columbia and Ontario. Of its 1,533 stores, 33% operate in four states California, Texas, Ohio, and Florida, and net sales from stores in these states represented 36% of its fiscal 2011 net sales.
Advisors' Opinion:- [By Jake L'Ecuyer]
Big Lots (NYSE: BIG) shares tumbled 13.14 percent to $32.25 after the company reported posted a Q3 loss of $0.17 per share on revenue of $1.15 billion.
- [By Rich Bieglmeier]
Big Lots, Inc. (NYSE:BIG) will announce its first-quarter, 2014 financial results on Friday, May 30, 2014 prior to the market open. On the same day, executives will discuss the financial results on a conference call at 8:00 a.m. Eastern Time.
- [By Jon C. Ogg]
Big Lots Inc. (NYSE: BIG)�was raised to Neutral from Underweight at J.P. Morgan.
Darling International Inc. (NYSE: DAR) was raised to Buy from Hold and the price target was raised to $25 from $22 at Canaccord Genuity.
10 Best Integrated Utility Stocks To Watch For 2014: China Yuchai International Limited (CYD)
China Yuchai International Limited, through its subsidiaries, manufactures and sells diesel and natural gas engines primarily in the People�s Republic of China (PRC). It operates in two segments, Yuchai and HLGE. The company provides engines for light, medium, and heavy-duty for highway vehicles; generator sets; and marine and industrial applications, as well as supplies after-market parts and services. It also offers diesel power generators that are used in the construction and mining industries; diesel engine parts; and remanufacturing services. In addition, the company operates hotels and engages in property development activities primarily in the PRC and Malaysia. It distributes its products directly to auto plants and agents. The company was founded in 1951 and is based in Singapore.
Advisors' Opinion:- [By Rich Duprey]
Following the abrupt resignation of director and President Benny H. Goh on May 27, China Yuchai International (NYSE: CYD ) has been operating with an interim officer, Kok Ho Leong,�who also held the position of CFO while a replacement was found.
10 Best Integrated Utility Stocks To Watch For 2014: ModusLink Global Solutions Inc(MLNK)
ModusLink Global Solutions, Inc., through its subsidiaries, provides supply chain business process management solutions worldwide. Its services and solutions cover forward supply chain, aftermarket service requirements, and e-business processes. The company?s services include sourcing and supply base management, manufacturing and product configuration, fulfillment and distribution, e-business, and aftermarket services, such as returns management and asset disposition; and consumer-electronics repair and reverse logistics services. Its clients include hardware manufacturers, software publishers, telecommunications carriers, broadband and wireless service providers, and consumer electronics companies. In addition, the company, through its venture capital business, invests in early-stage technology companies. ModusLink Global Solutions, Inc., formerly known as CMGI, Inc., was founded in 1986 and is headquartered in Waltham, Massachusetts.
Advisors' Opinion:- [By Monica Gerson]
ModusLink Global Solutions (NASDAQ: MLNK) fell 6.95% to $4.55 in pre-market trading after the company announced a proposed $75 million convertible senior notes offering.
10 Best Integrated Utility Stocks To Watch For 2014: support.com Inc.(SPRT)
Support.com, Inc. provides online care services for the digital home and small business primarily in North America. Its services and software products install, set up, connect, repair, and protect personal computers (PCs) and related devices that are essential to its customers; and it offers it as one-time services and subscriptions, and as software products to consumers who prefer do-it-yourself solutions. The company?s online care services include installation and setup services; connect and secure services that configure, connect, and establish secure connections between the computer, the wireless network, and supported devices; diagnose and repair services to identify, diagnose, and repair technical problems comprising the removal of viruses, spyware, and other forms of malware; and mobile device services. Its online care services also consist of tune-up services, which optimizes key systems settings for faster start-up and shut-down, loading of programs, and Internet browsing; online data backup; and server and network monitoring and management, hosted email and virtual desktops, and disaster recovery services. In addition, the company offers various software products, such as Advanced Registry Optimizer to identify and repair errors in the registry database on PCs; Cosmos software to maintain and optimize the performance of PCs; Hard Disk Tune-Up that improves the performance of a computer by defragmenting programs and data stored on the hard drive; MemTurbo, which increases available memory and improves PC performance; RapidStart software for removing or delaying unnecessary startup programs, processes, and services; and SUPERAntiSpyware software, an anti-malware technology. It provides its products and services through its channel partners and directly to consumers. The company was formerly known as SupportSoft, Inc. and changed its name to Support.com, Inc. in June 2009. Support.com, Inc. was founded in 1997 and is headquartered in Redwood City, California.
Advisors' Opinion:- [By Roberto Pedone]
Support.com (SPRT) is a provider of online care for the digital home and small business. This stock closed up 2.7% to $5.89 in Tuesday's trading session.
Tuesday's Range: $5.67-$5.92
52-Week Range: $3.67-$6.28
Thursday's Volume: 304,000
Three-Month Average Volume: 377,189From a technical perspective, SPRT spiked higher here right above its 50-day moving average of $5.51 with decent upside volume. This move also pushed shares of SPRT into breakout territory, since the stock took out some near-term overhead resistance at $5.80. Shares of SPRT have been uptrending for the last month, with the stock moving higher from its low of $5.01 to its intraday high of $5.92. During that uptrend, shares of SPRT have been consistently making higher lows and higher highs, which is bullish technical price action.
Traders should now look for long-biased trades in SPRT as long as it's trending above its 50-day at $5.51 or above more near-term support at $5.43 and then once it sustains a move or close above Tuesday's high of $5.92 to its 52-week high at $6.28 with volume that hits near or above 377,189 shares. If that breakout triggers soon, then SPRT will set up to enter new 52-week-high territory above $6.28, which is bullish technical price action. Some possible upside targets off that move are $7 to $8.
No comments:
Post a Comment